HOME > Business Development
ViroMed(doing business as VM Biopharma in the USA)is continuously growing, and is always looking for select partnerships and co-development opportunities for various clinical stages of the company’s product pipeline. We welcome both licensing deals and research collaborations.
Korea
Reyon Pharm.
Dream CIS
USA
Medtech Consultants, Inc.
Althea Technologies, Inc.
Clinical Supplies Management, Inc.
Charles River Laboratories Internationsl, Inc.
Synteract HCR, Inc.
Europe
Cobra Biologics, Ltd. (UK)
Genethon (France)
Oxford Biomedica (England))
Asia
Beijing Northland Biotech Co., Ltd.(China)
Please contact the business development department for more information.
Seungshin Yu, Ph.D
Director, New Business Planning Division
seungshin@viromed.co.kr
Sheila Yi
Director, US Clinical Development
sheila@viromed.co.kr